Targeting cancer at its root
developing novel drugs that attack Cancer Stem Cells
The Company
Pipeline
Cancer Stem Cells
Platform
Investor Relations
Organization
Scientific Presentations
Collaborations
Contact Us
Pre-Clinical Programs
